Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lindsay Lally

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Opinion in Rheumatology|November 25, 2015
B-cell-targeted therapy in systemic vasculitisLindsay Lally, Robert Spiera
Best Practice & Research. Clinical Rheumatology|August 21, 2019
Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practiceLindsay Lally, Robert Spiera
Annual Review of Medicine|October 24, 2014
Current therapies for ANCA-associated vasculitisLindsay Lally, Robert Spiera
Rheumatic Diseases Clinics of North America|November 18, 2014
Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatmentLindsay Lally, Robert Spiera
Nature Reviews. Rheumatology|January 8, 2024
Advances in the treatment of polymyalgia rheumatica and giant cell arteritisLindsay Lally, Robert Spiera
Current Rheumatology Reports|August 20, 2013
Biomarkers in ANCA-associated vasculitisLindsay Lally, Robert F Spiera
Current Allergy and Asthma Reports|July 11, 2020
Localized Granulomatous with Polyangiitis (GPA): Varied Clinical Presentations and Update on TreatmentSebastian E Sattui, Lindsay Lally
Rheumatic Diseases Clinics of North America|November 18, 2014
Vasculitis in antiphospholipid syndromeLindsay Lally, Lisa R Sammaritano
Rheumatic Diseases Clinics of North America|April 4, 2015
Pulmonary vasculitisLindsay Lally, Robert F Spiera
Arthritis & Rheumatology (Hoboken, N.J.)|May 10, 2016
Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia RheumaticaLindsay Lally, Lindsy Forbess, Christopher Hatzis, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Opinion in Rheumatology|November 25, 2015
B-cell-targeted therapy in systemic vasculitisLindsay Lally, Robert Spiera
Best Practice & Research. Clinical Rheumatology|August 21, 2019
Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practiceLindsay Lally, Robert Spiera
Annual Review of Medicine|October 24, 2014
Current therapies for ANCA-associated vasculitisLindsay Lally, Robert Spiera
Rheumatic Diseases Clinics of North America|November 18, 2014
Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatmentLindsay Lally, Robert Spiera
Nature Reviews. Rheumatology|January 8, 2024
Advances in the treatment of polymyalgia rheumatica and giant cell arteritisLindsay Lally, Robert Spiera
Current Rheumatology Reports|August 20, 2013
Biomarkers in ANCA-associated vasculitisLindsay Lally, Robert F Spiera
Current Allergy and Asthma Reports|July 11, 2020
Localized Granulomatous with Polyangiitis (GPA): Varied Clinical Presentations and Update on TreatmentSebastian E Sattui, Lindsay Lally
Rheumatic Diseases Clinics of North America|November 18, 2014
Vasculitis in antiphospholipid syndromeLindsay Lally, Lisa R Sammaritano
Rheumatic Diseases Clinics of North America|April 4, 2015
Pulmonary vasculitisLindsay Lally, Robert F Spiera
Arthritis & Rheumatology (Hoboken, N.J.)|May 10, 2016
Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia RheumaticaLindsay Lally, Lindsy Forbess, Christopher Hatzis, et al.
Pageof 2